Shares of Koninklijke Philips (NYSE:PHG – Get Free Report) have earned a consensus rating of “Hold” from the five ratings firms that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company.
A number of research analysts recently weighed in on PHG shares. StockNews.com downgraded shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th.
Get Our Latest Analysis on Koninklijke Philips
Koninklijke Philips Stock Performance
Hedge Funds Weigh In On Koninklijke Philips
Institutional investors have recently modified their holdings of the company. Fairscale Capital LLC acquired a new stake in Koninklijke Philips in the second quarter worth about $54,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Koninklijke Philips in the 3rd quarter worth approximately $54,000. CWM LLC boosted its holdings in shares of Koninklijke Philips by 21.9% in the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after acquiring an additional 616 shares in the last quarter. Eastern Bank acquired a new position in shares of Koninklijke Philips during the third quarter valued at approximately $88,000. Finally, Blue Trust Inc. raised its holdings in Koninklijke Philips by 902.7% during the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock worth $93,000 after purchasing an additional 3,331 shares in the last quarter. Institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- 3 REITs to Buy and Hold for the Long Term
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Manufacturing Stocks Investing
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Short Selling: How to Short a Stock
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.